Active Ingredient: CARBAMAZEPINE
Proprietary Name: CARNEXIV
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 200MG/20ML (10MG/ML)
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N206030
Product Number: 001
Approval Date: Oct 7, 2016
Applicant Holder Full Name: LUNDBECK PHARMACEUTICALS LLC
Marketing Status:
Discontinued
Patent and Exclusivity Information
